View in EDS

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer.
Authors: van Veggel, B.1 (AUTHOR), Madeira R Santos, J.F. Vilacha2 (AUTHOR), Hashemi, S.M.S.3 (AUTHOR), Paats, M.S.4 (AUTHOR), Monkhorst, K.5 (AUTHOR), Heideman, D.A.M.6 (AUTHOR), Groves, M.2 (AUTHOR), Radonic, T.6 (AUTHOR), Smit, E.F.1 (AUTHOR), Schuuring, E.7 (AUTHOR), van der Wekken, A.J.8 (AUTHOR), de Langen, A.J.1 (AUTHOR) j.d.langen@nki.nl
Source: Lung Cancer (01695002). Mar2020, Vol. 141, p9-13. 5p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first